Pharma News

The Sistema Group company Binnopharm Group, one of the leading pharmaceutical production companies in Russia via its affiliate Joint Stock Company Alium, and Dr. Reddys Laboratories Ltd an integrated global pharmaceutical company, today announced the signing of a deal that will allow Binnopharm Group to acquire anti-bacterial medicines under the Ciprolet and Levolet brands from Dr. Reddys in Russia, Uzbekistan and Belarus. The portfolio includes various dosage forms such as tablets, solution for infusions and eye drops.

Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Amantadine Hydrochloride Softgel Capsules USP, 100 mg from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc (Endo).

NIAB discover potential biomarker, NS 1 protein for Japanese encephalitis virus. Non-Structural 1 protein, a potential diagnostic biomarker for Japanese encephalitis virus. A diagnostic biomarker refers to a biological parameter that aids the diagnosis of a disease and may serve in determining disease progression or success of treatment.

Novartis to get approval for import and marketing of Dabrafenib, anticancer medicine for additonal indication from CDSCO. Subject Expert committee recommends CDSCO for grant of permission to import and marketing of Dabrafenib capsules 50 mg and 75 mg.

Novartis presented their proposal for import and marketing of the drug Dabrafenib capsules 50 mg and 75 mg for an additional indication, along with justification for clinical trial waiver before the committee.

Government eases the norms of manufacturing, stocking, sale or distribution of new drugs under phase III clinical trials, for the treatment of Covid-19 and related diseases. The provision is made to stock the drugs with a condition that it will sell the new drug only after obtaining permission as per the regulations.

Certain sections of the media have falsely linked again Giloy/Guduchi to liver damage. The Ministry of Ayush reiterates that Giloy/Gudduchi (Tinospora cordifolia) is safe and as per available data, Guduchi does not produce any toxic effect.

Lucknow based national laboratory CSIR-Central Drug Research Institute (CDRI), has licensed the technology of Nucleic Acid Staining Dye GreenR to GenetoProtein Pvt. Ltd., a start-up company registered in Uttar Pradesh in the year 2020. This startup is involved in developing an array of enzymes, kits and biochemical used in Lifesciences research, particularly molecular biology. The dye GreenR™ has been developed by CDRI Senior Principal Scientist Dr. Atul Goel in a joint collaborative project with an industry partner Biotech Desk Pvt. Ltd., Hyderabad.

Lupin Pharmaceuticals Inc announced that the U.S. Food and Drug Administration has approved the company s supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole) in the treatment of bacterial vaginosis (BV) for female patients 12 years of age and older and in the treatment of trichomoniasis for all patients 12 years of age and older.

A U.S. patient with leukemia has become the first woman and the third person to date to be cured of HIV after receiving a stem cell transplant from a donor who was naturally resistant to the virus that causes AIDS, researchers reported.

The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.